194 related articles for article (PubMed ID: 34153386)
1. Outcomes of pregnancy and childbirth in women with hidradenitis suppurativa.
Sakya SM; Hallan DR; Maczuga SA; Kirby JS
J Am Acad Dermatol; 2022 Jan; 86(1):61-67. PubMed ID: 34153386
[TBL] [Abstract][Full Text] [Related]
2. Effect of hidradenitis suppurativa on obstetric and neonatal outcomes.
Althagafi H; Spence AR; Czuzoj-Shulman N; Abenhaim HA
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):8388-8393. PubMed ID: 35135394
[TBL] [Abstract][Full Text] [Related]
3. Adverse pregnancy and maternal outcomes in women with hidradenitis suppurativa.
Fitzpatrick L; Hsiao J; Tannenbaum R; Strunk A; Garg A
J Am Acad Dermatol; 2022 Jan; 86(1):46-54. PubMed ID: 34126093
[TBL] [Abstract][Full Text] [Related]
4. Increased utilization of emergency department and inpatient care by patients with hidradenitis suppurativa.
Khalsa A; Liu G; Kirby JS
J Am Acad Dermatol; 2015 Oct; 73(4):609-14. PubMed ID: 26190241
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Hidradenitis Suppurativa Disease Course During Pregnancy and Postpartum.
Lyons AB; Peacock A; McKenzie SA; Jacobsen G; Naik HB; Shi VY; Hamzavi IH; Hsiao JL
JAMA Dermatol; 2020 Jun; 156(6):681-685. PubMed ID: 32347884
[TBL] [Abstract][Full Text] [Related]
6. Differences Between Children and Adults With Hidradenitis Suppurativa.
Hallock KK; Mizerak MR; Dempsey A; Maczuga S; Kirby JS
JAMA Dermatol; 2021 Sep; 157(9):1095-1101. PubMed ID: 34379074
[TBL] [Abstract][Full Text] [Related]
7. Women of Childbearing Age With Hidradenitis Suppurativa Frequently Prescribed Medications With Pregnancy Risk.
Rivin GM; Fleischer AB
J Drugs Dermatol; 2023 Jul; 22(7):706-709. PubMed ID: 37410037
[TBL] [Abstract][Full Text] [Related]
8. Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement.
Deckers IE; van der Zee HH; Boer J; Prens EP
J Am Acad Dermatol; 2015 Mar; 72(3):485-8. PubMed ID: 25582541
[TBL] [Abstract][Full Text] [Related]
9. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.
Shlyankevich J; Chen AJ; Kim GE; Kimball AB
J Am Acad Dermatol; 2014 Dec; 71(6):1144-50. PubMed ID: 25440440
[TBL] [Abstract][Full Text] [Related]
10. Association between Hidradenitis Suppurativa and Inflammatory Arthritis: A Systematic Review and Meta-Analysis.
Almuhanna N; Finstad A; Alhusayen R
Dermatology; 2021; 237(5):740-747. PubMed ID: 33774640
[TBL] [Abstract][Full Text] [Related]
11. Patient Perspectives on Hidradenitis Suppurativa and Infertility: A Survey Study.
Masson R; Shih T; Park S; De DR; Gierbolini A; Alavi A; Garg A; Micheletti RG; Shi VY; Hsiao JL
Dermatology; 2023; 239(5):732-737. PubMed ID: 37385230
[TBL] [Abstract][Full Text] [Related]
12. Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States.
Cosmatos I; Matcho A; Weinstein R; Montgomery MO; Stang P
J Am Acad Dermatol; 2013 Mar; 68(3):412-9. PubMed ID: 22921795
[TBL] [Abstract][Full Text] [Related]
13. Risk of psoriasis in people with hidradenitis suppurativa: A systematic review and meta-analysis.
Gau SY; Preclaro IAC; Wei JC; Lee CY; Kuan YH; Hsiao YP; Juang SE; Ma KS
Front Immunol; 2022; 13():1033844. PubMed ID: 36532043
[TBL] [Abstract][Full Text] [Related]
14. Hidradenitis suppurativa and association with stroke: systematic review and meta-analysis.
Phan K; Ng WHS; Lai B; Garg A; Smith SD
J Dermatolog Treat; 2022 Jun; 33(4):2309-2316. PubMed ID: 34289795
[TBL] [Abstract][Full Text] [Related]
15. Health care utilization patterns and costs for patients with hidradenitis suppurativa.
Kirby JS; Miller JJ; Adams DR; Leslie D
JAMA Dermatol; 2014 Sep; 150(9):937-44. PubMed ID: 24908260
[TBL] [Abstract][Full Text] [Related]
16. Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.
Condamina M; Penso L; Tran VT; Hotz C; Guillem P; Villani AP; Perrot P; Bru MF; Jacquet E; Nassif A; Bachelez H; Wolkenstein P; Beylot-Barry M; Richard MA; Ravaud P; Viguier M; Sbidian E
Dermatology; 2021; 237(5):748-758. PubMed ID: 33503635
[TBL] [Abstract][Full Text] [Related]
17. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
Zouboulis CC; Desai N; Emtestam L; Hunger RE; Ioannides D; Juhász I; Lapins J; Matusiak L; Prens EP; Revuz J; Schneider-Burrus S; Szepietowski JC; van der Zee HH; Jemec GB
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):619-44. PubMed ID: 25640693
[TBL] [Abstract][Full Text] [Related]
18. Factors Associated With Dermatologic Follow-up vs Emergency Department Return in Patients With Hidradenitis Suppurativa After an Initial Emergency Department Visit.
Wang CX; Buss JL; Keller M; Anadkat MJ
JAMA Dermatol; 2022 Dec; 158(12):1378-1386. PubMed ID: 36287553
[TBL] [Abstract][Full Text] [Related]
19. Swiss Practice Recommendations for the Management of Hidradenitis Suppurativa/Acne Inversa.
Hunger RE; Laffitte E; Läuchli S; Mainetti C; Mühlstädt M; Schiller P; Lapointe AK; Meschberger P; Navarini AA
Dermatology; 2017; 233(2-3):113-119. PubMed ID: 28683447
[TBL] [Abstract][Full Text] [Related]
20. Impact of Pregnancy on Hidradenitis Suppurativa Disease Course: A Systematic Review and Meta-Analysis.
Seivright JR; Villa NM; Grogan T; Parvataneni RK; Thompson AM; Shi VY; Hsiao JL
Dermatology; 2022; 238(2):260-266. PubMed ID: 34515085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
